Transition Therapeutics Inc. TTHI was a big mover last session, as its shares rose nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the trend of the company since April 9, as the stock is now down over 31%.
In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Transition Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Other better-ranked stocks in the medical sector include ANI Pharmaceuticals, Inc. ANIP, ZIOPHARM Oncology, Inc. ZIOP and Alexion Pharmaceuticals, Inc. ALXN. While ANI Pharmaceuticals and ZIOPHARM Oncology sport a Zacks Rank #1 (Strong Buy), ALexion carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ALEXION PHARMA ALXN: Free Stock Analysis Report
ANI PHARMACEUT ANIP: Free Stock Analysis Report
TRANSITN THERAP TTHI: Get Free Report
ZIOPHARM ONCLGY ZIOP: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Market News and Data brought to you by Benzinga APIsIn the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Transition Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
Other better-ranked stocks in the medical sector include ANI Pharmaceuticals, Inc. ANIP, ZIOPHARM Oncology, Inc. ZIOP and Alexion Pharmaceuticals, Inc. ALXN. While ANI Pharmaceuticals and ZIOPHARM Oncology sport a Zacks Rank #1 (Strong Buy), ALexion carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ALEXION PHARMA ALXN: Free Stock Analysis Report
ANI PHARMACEUT ANIP: Free Stock Analysis Report
TRANSITN THERAP TTHI: Get Free Report
ZIOPHARM ONCLGY ZIOP: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
